Business · 14/02/2012
FDA Releases Draft Guidance for PET Drug IND Applications
The Food and Drug Administration (FDA) has made available a draft guidance document to help manufacturers of Positron Emission Tomography (PET) drugs prepare and submit Investigational New Drug Applications (INDs).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →